EP4209493
Föst form og samsetningar af (S)-4-(8-amínó-3-(1-(bút-2-ýnóýl)pyrrólidín-2-ýl)imídasó[1,5-a]pýrasín-1-ýl)-N-(pýridín-2-ýl)bensamíði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.7.2016EP published:
12.11.2025EP application number:
23157244.7
EP translation filed:
14.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
30.6.2036Expiry date:
30.6.2026
Title in English:
SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDELanguage of the patent:
English
Timeline
Today
1.7.2016EP application
12.11.2025EP Publication
14.1.2026Translation submitted
11.2.2026Registration published
30.6.2026Expires
Owner
Name:
Acerta Pharma B.V.Address:
Kloosterstraat 9, 5349 AB Oss, NL
Inventor
Name:
BLATTER, FritzAddress:
4153 Reinach, CH
Name:
INGALLINERA, TimAddress:
San Francisco, 94117, US
Name:
BARF, TjeerdAddress:
5371 AS Ravenstein, NL
Name:
ARET, EdwinAddress:
1333 CJ Almere, NL
Name:
KREJSA, CecileAddress:
Seattle, 98117, US
Name:
EVARTS, JerryAddress:
Bellevue, 98007, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562188468 PDate:
2.7.2015Country:
US
Number:
201562271708 PDate:
28.12.2015Country:
US
Classification
Categories:
C07D 487/04, A61K 31/4985, A61P 35/00